Stock News

Company Update (NASDAQ:AAPL): Apple Inc Updates Final Cut Pro X, Motion and Compressor

Apple Inc (NASDAQ:AAPL) updated Final Cut Pro® X, Motion and Compressor with new features for motion graphics and key enhancements to accelerate video …

Company Update (NASDAQ:GPRO): GoPro Inc Unveils HEROCast™, the Smallest, Lightest Professional Live-Broadcast Transmitter to Hit the Market

GoPro, Inc (NASDAQ:GPRO), enabler of some of today’s most engaging content, today announced the launch of HEROCast™, the smallest, lightest, and most cost-efficient wireless …

Stock Update (NASDAQ:MSFT): Microsoft Corporation Hires Kurt DelBene to Head Corporate Strategy and Planning

Microsoft Corporporation (NASDAQ:MSFT) announced that Kurt DelBene has been named executive vice president of Corporate Strategy and Planning reporting to Microsoft Chief Executive …

Company Update (NASDAQ:EXAS): Cologuard® Receives Coverage by Several Commercial Health Plans in Q1 2015

EXACT Sciences Corporation (NASDAQ:EXAS) announced expanded patient access to Cologuard as a result of several insurers now covering the test. Cologuard is now covered …

Company Update (NYSE:HLF): Herbalife Ltd. Strengthens Nutrition Advisory Board with Addition of Prominent Czech Gastroenterologist

Global nutrition company, Herbalife Ltd. (NYSE:HLF), announced that leading Czech gastroenterologist, Dr.

Company Update (NASDAQ:AMD): Advanced Micro Devices, Inc. and Avid Join Forces to Power Exceptional 4K Workflow Performance

Advanced Micro Devices, Inc. (NASDAQ:AMD) announced certification for Avid Media Composer® 8.

Company Update (NASDAQ:CYTX): Cytori Therapeutics Inc Provides Twelve Month Data Update on Scleradec-I Trial

Cytori Therapeutics Inc (NASDAQ:CYTX) announced today preliminary 12 month follow-up data from the 12 patient investigator initiated Scleradec-I clinical trial conducted by Prof. …

Company Update (NASDAQ:ARWR): Arrowhead Research Corp Cleared to Proceed with Multiple Dose Phase 2b Study of ARC-520

Arrowhead Research Corp (NASDAQ:ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, announced that the United States Food and Drug Administration (FDA) informed the …

Stock Update (NASDAQ:GALE): Galena Biopharma Inc Announces Closing of Over-Allotment Option, Increasing Total Gross Proceeds to $43.7 Million

Galena Biopharma Inc (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of …

Company Update (NASDAQ:ECYT): Endocyte, Inc. Announces Presentations at American Association for Cancer Research (AACR) 2015 Annual Meeting

Endocyte, Inc. (NASDAQ:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts